Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Post by scarlet1967on Nov 01, 2023 6:51pm
179 Views
Post# 35712350

Insanity or indecency?

Insanity or indecency?

 

People who suffer from insanity don't have a choice. On the other hand people who are indecent have had a choice. To me the timing/terms of the first offering was ugly but the marathon loan was uglier. The last offering is by far the ugliest. They didn't only crush the valuation and loyal longterm shareholders but also their own already questionable credibility. Insider buying at multi year lows not far from all time lows doesn't make me feel any better about how badly they have managed the company. For those who weren't around at the time of the all time low valuation they had manufacturing issues with Egrifta which was the company's main and only asset. Now they have two commercial drugs and the R&D assets. Point is why the market ascribes almost the same value to the company now as it did in 2013? Who is responsible for the putting it mildly the negative perception? Name and shame who ever you think are responsible but surely they don't deserve their compensations on the contrary they should move on and let new folks do what they are not "capable" of doing.

This last offering to me was the last nail in the coffin. Unfortunately it's too late to sell so I guess the long term shareholders now have to put up but in my opinion never shut up. I voted against majority of the board members in the last few years next time round it will be against all of them. The scientific team in my opinion is a crucial part of the company now crushed too so the CEO can stay on his compensation. I had high expectations when he was appointed a marketing strategist with skills necessary to increase sales and present the company's business. The higher expectations if not materialized the higher disappointments and that's what I feel about it now. For those who claim the last round of layoffs don't include R&D folks involved with oncology feel free and check company's LinkedIn people page(while they are still there) and try to find 25 people who can be classified as R&D excluding the scientists involved in the oncology research. Good luck with that cause you need it. Yes very negative assessment but not far from the truth in my opinion.

<< Previous
Bullboard Posts
Next >>